Related Experiment Video
Updated: Mar 14, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Treat-to-target (T2T) recommendations for gout
U Kiltz1, J Smolen2, T Bardin3
1Rheumazentrum Ruhrgebiet, and Ruhr University Bochum, Herne, Germany.
This study developed the first international treat-to-target (T2T) recommendations for gout management. The guidelines focus on normalizing serum urate levels to reduce chronic pain and inflammation, improving patient outcomes.
Area of Science:
- Rheumatology
- Gout Management
- Inflammatory Diseases
Background:
- Gout is a chronic inflammatory disease characterized by high serum urate levels.
- The treat-to-target (T2T) concept has proven effective in managing other rheumatic diseases.
- Applying T2T to gout is logical due to its strong link with serum urate levels.
Framework:
- Developed four overarching principles for gout management.
- Established nine treat-to-target (T2T) recommendations for gout.
- Focused on achieving normal serum urate levels as a primary target.
Implementation:
- Expert consensus guided the development of T2T recommendations.
- Systematic literature review informed the evidence base.
- Recommendations were based on indirect evidence and expert agreement.
Implications:
- These represent the first T2T recommendations specifically for gout.
- The principles emphasize crystal dissolution and flare prevention.
- Patient education, medication adherence, and serum urate monitoring are crucial.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Nephrotic Syndrome II : Assessment and Medical Management
Atherosclerosis III: Management
